Content about Monoclonal antibodies

October 20, 2010
Genentech's Herceptin receives FDA approval

The Food and Drug Administration has approved a biotech drug for treating cancer of the...

October 5, 2010
Amgen: Vectibix improves progression-free survival for cancer patients

An investigative biotech drug administered together with chemotherapy helped extend the lives of cancer patients...

October 4, 2010
Decision Resources projects modest growth for UC drug market

The drug market for ulcerative colitis treatments will see modest growth through 2019, according to...

September 29, 2010
Centocor Ortho Biotech seeks expanded approval for Simponi

The biotech division of Johnson & Johnson is hoping to expand the use of a...

September 28, 2010
Decision Resources: Crohn's disease drug market will increase 31% by 2019

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 28, 2010
Oncologists favor biosimilar adoption, Decision Resources finds

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...

September 19, 2010
Genentech amends approval application for expanded use of Avastin

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

September 13, 2010
Seattle Genetics, Genmab to develop cancer therapeutics

Biotech companies Seattle Genetics and Genmab will collaborate to develop antibody treatments for cancer, the...

September 8, 2010
GSK, Genmab begin late-stage clinical trial for cancer drug

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

August 31, 2010
FDA expedites review of Alimera's Iluvien

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

August 29, 2010
MedImmune confirms second CRL from FDA for motavizumab

AstraZeneca's biologics unit has received a second complete response letter from the Food and Drug...

August 18, 2010
FDA grants priority review for Benlysta

The Food and Drug Administration has decided to expedite the review of an investigational drug...

August 17, 2010
FDA grants priority review for Bristol-Myer Squibb's skin cancer treatment

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

August 11, 2010
Amgen's Vectibix fails to meet main goal in trial

An investigational biotech drug didn’t significantly improve patients’ survival, according to results of a late-stage...

August 4, 2010
Amgen's sales, profits rise in Q2

Biotech company Amgen had $3.8 billion in sales and $1.33 billion in profits during second...

August 1, 2010
Merck discloses Q2 earnings

Merck had global sales of $11.3 billion and profits of $752 million during second quarter...

July 20, 2010
FDA advisory committee recommends limiting use of Genentech breast cancer drug

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

July 18, 2010
Amgen gets priority review from FDA

The Food and Drug Administration has given priority review to an application from Amgen for...

July 12, 2010
Lonza to help manufacture Human Genome Sciences' Benlysta

A developer of a new drug for treating lupus has entered a supply agreement with...

June 30, 2010
GSK, Genmab ink deal to develop, commercialize ofatumumab

British drug maker GlaxoSmithKline has inked a co-development and commercialization agreement with Genmab, the drug...

June 23, 2010
Pfizer suspends tanezumab trial per FDA's request

Reports of worsening conditions among patients has led drug maker Pfizer to suspend a clinical...

June 22, 2010
FDA approves Lucentis for vision loss-related disease

The Food and Drug Administration has approved a drug made by Genentech for treating a...

June 22, 2010
Orphan drug designation for Tolera's diabetes drug

The Food and Drug Administration has granted orphan drug designation to an investigational treatment for...

June 21, 2010
Datamonitor: Melanoma cases expected to double

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...

June 15, 2010
Patient enrollment complete for lung cancer treatment trial

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

© 2013 Drug Store News. All Rights Reserved.